We are live on ! Find out more
Voloridge Investment Management

Voloridge Investment Management Portfolio holdings

AUM $25B
1-Year Est. Return 28.08%
This Fund
S&P 500
This Quarter Est. Return
-22.63%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$3.48B
AUM Growth
-$1.65B
Cap. Flow
-$437M
Cap. Flow %
-12.56%
Top 10 Hldgs %
17.12%
Holding
1,564
New
520
Increased
250
Reduced
281
Closed
513

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$234M
2
TSLA icon
Tesla
TSLA
+$114M
3
BA icon
Boeing
BA
+$93.2M
4
AMZN icon
Amazon
AMZN
+$84.2M
5
AMD icon
Advanced Micro Devices
AMD
+$65.5M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 13.1%
2 Financials 12.66%
3 Healthcare 10.05%
4 Technology 9.61%
5 Communication Services 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COHR
1501
DELISTED
Coherent Inc
COHR
-12,646
Closed -$2.1M
IIN
1502
DELISTED
IntriCon Corporation
IIN
-11,134
Closed -$200K
ATRS
1503
DELISTED
Antares Pharma, Inc.
ATRS
-54,753
Closed -$257K
PTE
1504
DELISTED
PolarityTE, Inc. Common Stock
PTE
-631
Closed -$41K
XENT
1505
DELISTED
Intersect ENT, Inc
XENT
-15,774
Closed -$393K
EPAY
1506
DELISTED
Bottomline Technologies Inc
EPAY
-36,939
Closed -$1.98M
ARNA
1507
DELISTED
Arena Pharmaceuticals Inc
ARNA
-24,021
Closed -$1.09M
RDS.A
1508
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
-208,437
Closed -$12.3M
RDS.B
1509
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
-176,248
Closed -$10.6M
DRNA
1510
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-43,868
Closed -$966K
HRC
1511
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
-31,193
Closed -$3.54M
RPAI
1512
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
-15,368
Closed -$206K
PFPT
1513
DELISTED
Proofpoint, Inc.
PFPT
-4,407
Closed -$506K
SYKE
1514
DELISTED
SYKES Enterprises Inc
SYKE
-9,698
Closed -$359K
MXIM
1515
DELISTED
Maxim Integrated Products
MXIM
-3,517
Closed -$216K
WORK
1516
DELISTED
Slack Technologies, Inc.
WORK
-30,502
Closed -$686K
PRAH
1517
DELISTED
PRA Health Sciences, Inc.
PRAH
-21,942
Closed -$2.44M
RP
1518
DELISTED
RealPage, Inc.
RP
-32,594
Closed -$1.75M
EGOV
1519
DELISTED
NIC Inc
EGOV
-17,891
Closed -$400K
IPHI
1520
DELISTED
INPHI CORPORATION
IPHI
-53,057
Closed -$3.93M
MIK
1521
DELISTED
Michaels Stores, Inc
MIK
-85,750
Closed -$694K
PS
1522
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
-92,874
Closed -$1.6M
FBM
1523
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
-16,956
Closed -$328K
EIDX
1524
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
-3,872
Closed -$222K
PE
1525
DELISTED
PARSLEY ENERGY INC
PE
-301,546
Closed -$5.7M

Similar funds

Voloridge Investment Management's Q1 2020 Portfolio in Review

As of Q1 2020, Voloridge Investment Management held 1,564 positions worth $3.48B, down 32% from $5.13B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Voloridge Investment Management withdrew a net $437M in Q1 2020, closing 513 positions and reducing 281 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $234M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Voloridge Investment Management opened a new position in AT&T worth $65.2M.

  • Voloridge Investment Management's largest Q1 2020 buy was AT&T: 2,962,997 shares worth $65.2M.
  • Voloridge Investment Management added most to Comcast in Q1 2020, an estimated $84.8M increase.
  • Voloridge Investment Management's biggest Q1 2020 reduction was Tesla, cutting an estimated $114M.
  • Voloridge Investment Management fully exited State Street SPDR S&P 500 ETF Trust in Q1 2020, selling an estimated $234M.
  • Voloridge Investment Management's ten largest holdings make up 17% of its $3.48B portfolio in Q1 2020.
  • Voloridge Investment Management opened 520 new positions and closed 513 in Q1 2020.
  • Voloridge Investment Management's portfolio value fell 32% quarter-over-quarter to $3.48B.

Based on Voloridge Investment Management's 13F filing for Q1 2020, filed 15 May 2020.